The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 24, 2025

Filed:

Oct. 26, 2018
Applicants:

Baylor College of Medicine, Houston, TX (US);

William Marsh Rice University, Houston, TX (US);

Inventors:

Tatiana Y. Fofanova, Houston, TX (US);

Jennifer Auchtung, Houston, TX (US);

Reid Laurence Wilson, Houston, TX (US);

Christopher Stewart, Houston, TX (US);

Joseph Petrosino, Houston, TX (US);

Robert Allen Britton, Houston, TX (US);

Jane Grande-Allen, Houston, TX (US);

Noah F. Shroyer, Houston, TX (US);

Mary K. Estes, Houston, TX (US);

Assignees:

Baylor College of Medicine, Houston, TX (US);

William Marsh Rice University, Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
B01L 1/02 (2006.01); B01L 3/00 (2006.01); C12M 1/12 (2006.01); C12M 1/34 (2006.01); C12N 1/14 (2006.01); C12N 7/00 (2006.01); C40B 30/06 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
B01L 1/025 (2013.01); B01L 3/5085 (2013.01); C12M 25/02 (2013.01); C12M 25/04 (2013.01); C12M 41/34 (2013.01); C12N 1/14 (2013.01); C12N 7/00 (2013.01); C40B 30/06 (2013.01); G01N 33/5008 (2013.01); G01N 33/569 (2013.01); B01L 2300/042 (2013.01); B01L 2300/048 (2013.01);
Abstract

An anaerobic chamber system to evaluate human enteric disease is described herein that can be used to test therapeutic components. In specific embodiments, the anaerobic chamber is used to determine the effect of one or more bacterial communities on ex vivo enteroid cultures. In one application, the anaerobic chamber system is used to determine the efficacy of therapeutic components in ameliorating human enteric disease using personalized medicine.


Find Patent Forward Citations

Loading…